Loading...
Anti–Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position Paper
Biologic therapy with anti–tumor necrosis factor (TNF)-α antibody medications has become part of the standard of care for medical therapy for patients with inflammatory bowel disease and may help to avoid surgery in some. However, many of these patients will still require surgical intervention in th...
Na minha lista:
| Udgivet i: | Inflamm Bowel Dis |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4623843/ https://ncbi.nlm.nih.gov/pubmed/26422516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000000603 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|